These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24183329)

  • 1. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis.
    Braga GC; Brito MB; Ferriani RA; Oliveira LC; Garcia AA; Pintão MC; Vieira CS
    Contraception; 2014 Jan; 89(1):48-53. PubMed ID: 24183329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers among women with thrombophilia or previous venous thromboembolism.
    Braga GC; Brito MB; Ferriani RA; Oliveira LC; Garcia AA; Pintão MC; Vieira CS
    Int J Gynaecol Obstet; 2020 Mar; 148(3):381-385. PubMed ID: 31778208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
    Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
    J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M; Odlind V
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding pattern and safety of consecutive use of the levonorgestrel-releasing intrauterine system (LNG-IUS)--a multicentre prospective study.
    Gemzell-Danielsson K; Inki P; Boubli L; O'Flynn M; Kunz M; Heikinheimo O
    Hum Reprod; 2010 Feb; 25(2):354-9. PubMed ID: 19955104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
    Selim MF; Hussein AF
    Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy.
    Brull EP; Fernandes A; Monteiro I; Bahamondes L; Juliato CRT
    Int J Gynaecol Obstet; 2020 Dec; 151(3):355-361. PubMed ID: 32966599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system.
    Heikinheimo O; Inki P; Kunz M; Gemzell-Danielsson K
    Hum Reprod; 2010 Jun; 25(6):1423-7. PubMed ID: 20378611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
    Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
    Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
    Bahamondes MV; Monteiro I; Castro S; Espejo-Arce X; Bahamondes L
    Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
    Kaunitz AM; Bissonnette F; Monteiro I; Lukkari-Lax E; DeSanctis Y; Jensen J
    Contraception; 2012 Nov; 86(5):452-7. PubMed ID: 22959906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.